An Analysis of Judicial Cases Concerning Analgesic-Related Medication Errors in the Republic of Korea.
Journal
Journal of patient safety
ISSN: 1549-8425
Titre abrégé: J Patient Saf
Pays: United States
ID NLM: 101233393
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
entrez:
21
2
2022
pubmed:
22
2
2022
medline:
24
2
2022
Statut:
ppublish
Résumé
Analgesic-related medication errors can be a threat to patient safety. This study aimed to identify and describe medication errors that can cause serious adverse drug events (ADEs) related to analgesic use. This retrospective, observational, medicolegal study analyzed closed cases concerning complications induced by medication errors involving 3 commonly used analgesics: opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen (AAP). Cases closed between 1994 and 2019 that were available in the Korean Supreme Court judgment database system were included. Medication errors were categorized using a classification system (developed by our group) based on the stage of drug administration. Clinical characteristics and judgment statuses were analyzed. A total of 71 cases were included in the final analysis (opioids, n = 30; NSAIDs, n = 35; AAP, n = 6). Among them, 43 claims (60.6%) resulted in payments to the plaintiffs, with a median payment of $86,607 (interquartile range, $34,554-$193,782). The severity of ADEs was high (National Association of Insurance Commissioners scale ≥6) in 88.7% (n = 63) of claims, with a total of 44 (62%) deaths. The most common types of ADEs associated with opioid, NSAID, and AAP use were respiratory depression, anaphylactic shock, and fulminant hepatitis, respectively. The most common recognized medication errors associated with opioid, NSAIDs, and AAP were inappropriate patient monitoring (n = 10; 33.3%), improper analgesic choice (n = 15; 42.9%), and inappropriate treatment after ADEs (n = 3; 50%), respectively. Our findings indicate that efforts should be made to reduce medication errors related to analgesic use to prevent permanent injury and potential malpractice claims.
Identifiants
pubmed: 35188932
doi: 10.1097/PTS.0000000000000834
pii: 01209203-202203000-00019
doi:
Substances chimiques
Analgesics
0
Analgesics, Opioid
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e439-e446Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors disclose no conflict of interest.
Références
NCC MERP. National Coordinating Council for Medication Error Reporting and Prevention. About medication errors: what is a medication error? Available at: https://www.nccmerp.org/about-medication-errors . Accessed May 28, 2020.
Barker KN, Flynn EA, Pepper GA, et al. Medication errors observed in 36 health care facilities. Arch Intern Med . 2002;162:1897–1903.
Levinson DR. Adverse Events in Hospitals: National Incidence Among Medicare Beneficiaries . Washington, DC: Office of the Inspector General, Dept of Health and Human Services; 2010.
Kim K-H, Seo H-J, Abdi S, et al. All about pain pharmacology: what pain physicians should know. Korean J Pain . 2020;33:108–120.
Brophy T, Spiller H, Casavant M, et al. Medication errors reported to US poison control centers, 2000–2012. Clin Toxicol . 2014;52:880–888.
Giummarra MJ, Gibson SJ, Allen AR, et al. Polypharmacy and chronic pain: harm exposure is not all about the opioids. Pain Med . 2015;16:472–479.
Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol . 2009;22:588–593.
Cho SI, Shin S, Jung H, et al. Analysis of judicial precedent cases regarding epidural injection in chronic pain management in Republic of Korea. Reg Anesth Pain Med . 2020;45:337–343.
Blumenthal D. Making medical errors into ‘medical treasures’. JAMA . 1994;272:1867–1868.
Kim J, Shin S, Jeong Y, et al. Medicolegal consideration to prevent medical malpractice regarding opioid administration: an analysis of judicial opinion in South Korea. J Pain Res . 2020;13:1525–1532.
Sowka M. The medical malpractice closed claims study. Conducted by the National Association of Insurance Commissioners. Conn Med . 1981;45:91–101.
Ho KY. Perceptions and beliefs regarding NSAIDs in the Asia-Pacific Region. J Pain Res . 2020;13:437–446.
Bicket MC, Kattail D, Yaster M, et al. An analysis of errors, discrepancies, and variation in opioid prescriptions for adult outpatients at a teaching hospital. J Opioid Manag . 2017;13:51–57.
Beaudoin FL, Merchant RC, Janicki A, et al. Preventing iatrogenic overdose: a review of in–emergency department opioid-related adverse drug events and medication errors. Ann Emerg Med . 2015;65:423–431.
Morimoto T, Sakuma M, Matsui K, et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med . 2011;26:148–153.
Dornan T, Ashcroft D, Heathfield H, et al. An In-depth Investigation Into Causes of Prescribing Errors by Foundation Trainees in Relation to Their Medical Education: EQUIP Study . London: General Medical Council; 2009:1–215.
Lahue BJ, Pyenson B, Iwasaki K, et al. National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs. Am Health Drug Benefits . 2012;5:1–10.
Kanjanarat P, Winterstein AG, Johns TE, et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm . 2003;60:1750–1759.
Hyeon CW, Lee JY, Jang S, et al. Medical malpractice related to drug-induced anaphylaxis: an analysis of lawsuit judgments in South Korea. Medicine . 2019;98:e15996.
Kim E-J, Lim H, Park SY, et al. Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen. Asia Pac Allergy . 2014;4:68–72.
Yang M-S, Lee JY, Kim J, et al. Searching for the culprit drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis from a nationwide claim database in Korea. J Allergy Clin Immunol Pract . 2020;8:690–95.e2.
Mishra P, Stringer M. Sciatic nerve injury from intramuscular injection: a persistent and global problem. Int J Clin Pract . 2010;64:1573–1579.
Kim S-K, Kim T-H, Lee K-C. Nicolau syndrome after intramuscular injection: 3 cases. Arch Plast Surg . 2012;39:249–252.
Ogston-Tuck S. Intramuscular injection technique: an evidence-based approach. Nurs Stand . 2014;29:52–59.
Perry A, Potter P, Ostendorf W. Clinical Skills and Nursing Techniques . 8th ed. St Louis, MO: Elsevier-Mosby; 2014.
Jensen L, Merry A, Webster C, et al. Evidence-based strategies for preventing drug administration errors during anaesthesia. Anaesthesia . 2004;59:493–504.
Forster AJ, Murff HJ, Peterson JF, et al. Adverse drug events occurring following hospital discharge. J Gen Intern Med . 2005;20:317–323.
Bricker L, Lavender T. Parenteral opioids for labor pain relief: a systematic review. Am J Obstet Gynecol . 2002;186:S94–S109.
Koren G, Florescu A, Costei AM, et al. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother . 2006;40:824–829.
Liew Z, Ritz B, Rebordosa C, et al. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr . 2014;168:313–320.
Mahajan R. Critical incident reporting and learning. Br J Anaesth . 2010;105:69–75.